Developing Individualized Strategies to Prevent Nausea and Vomiting

NCT01393288 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Postoperative Nausea and Vomiting
Genetic Polymorphisms

Interventions

DRUG: Ondansetron
DRUG: Lorazepam
DRUG: Aprepitant

Sponsor

University of California, San Francisco

Collaborators

[object Object]